Literature DB >> 26885268

Protective effect of carnosine after chronic cerebral hypoperfusion possibly through suppressing astrocyte activation.

Jing Ma1, Jihui Chen1, Shuhong Bo1, Xiaotong Lu1, Jian Zhang1.   

Abstract

AIM: Subcortical ischemic vascular dementia (SIVD) induced by chronic hypoperfusion is a common cause of vascular dementia. The aim of this study was to determine whether the protective effect of carnosine on white matter lesion after chronic cerebral hypoperfusion through suppressing astrocyte activation.
METHODS: Adult male mice (C57BL/6 strain) were subjected to permanent occlusion of the right unilateral common carotid arteries (rUCCAO) and treated with carnosine or histidine. Open field test, freezing test, Klüver-Barrera staining, immunohistochemical analyses and western blot were performed after rUCCAO.
RESULTS: We found that carnosine ameliorated white matter lesion and cognitive impairment after rUCCAO. Carnosine suppressed the activation of astrocyte in both wide type mice and histidine decarboxylase knockout mice. However, administration of histidine did not show the same effect. We found that there were no differences between rUCCAO group and sham group for the expression of glutamate transporter-1 (GLT-1) and glutamate/aspartate transporter (GLAST). Furthermore, carnosine significantly attenuated the increase of inflammatory cytokine interferon gama.
CONCLUSION: These data suggest carnosine induced neuroprotection during SIVD in mice is not dependent on the histaminergic pathway or the regulation of the expression of GLT-1 and GLAST, but may be due to a suppression of astrocyte activation and inflammatory cytokine release.

Entities:  

Keywords:  Astrocyte; carnosine; interferon gama; subcortical ischemic vascular dementia; white matter injury

Year:  2015        PMID: 26885268      PMCID: PMC4731668     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  35 in total

Review 1.  Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic.

Authors:  Mark A Babizhayev; Yegor E Yegorov
Journal:  Recent Pat Drug Deliv Formul       Date:  2010-11

Review 2.  Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.

Authors:  Perttu Johannes Lindsberg; Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

3.  Neuronal activity and AMPA-type glutamate receptor activation regulates the morphological development of oligodendrocyte precursor cells.

Authors:  Jessica Fannon; Wysnavie Tarmier; Daniel Fulton
Journal:  Glia       Date:  2015-03-04       Impact factor: 7.452

4.  Renoprotective effects of l-carnosine on ischemia/reperfusion-induced renal injury in rats.

Authors:  Hayato Kurata; Toshihide Fujii; Hidenobu Tsutsui; Tomoaki Katayama; Mamoru Ohkita; Masanori Takaoka; Nobuo Tsuruoka; Yoshinobu Kiso; Yukihiro Ohno; Yoshihide Fujisawa; Takatoshi Shokoji; Akira Nishiyama; Youichi Abe; Yasuo Matsumura
Journal:  J Pharmacol Exp Ther       Date:  2006-08-17       Impact factor: 4.030

5.  Modulation of astrocytic glutamine synthetase expression and cell viability by histamine in cultured cortical astrocytes exposed to OGD insults.

Authors:  Xiao-Fen Wang; Wei-Wei Hu; Hai-Jing Yan; Li Tan; Jie-Qiong Gao; Yue-Yang Tian; Xiao-Jie Shi; Wei-Wei Hou; Juan Li; Yao Shen; Zhong Chen
Journal:  Neurosci Lett       Date:  2013-06-18       Impact factor: 3.046

6.  Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro.

Authors:  C Agresti; D D'Urso; G Levi
Journal:  Eur J Neurosci       Date:  1996-06       Impact factor: 3.386

Review 7.  Physiology and pathophysiology of carnosine.

Authors:  Alexander A Boldyrev; Giancarlo Aldini; Wim Derave
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

Review 8.  Vascular dementia.

Authors:  Amos D Korczyn; Veronika Vakhapova; Lea T Grinberg
Journal:  J Neurol Sci       Date:  2012-05-08       Impact factor: 3.181

Review 9.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

10.  Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.

Authors:  Carine Savarin; David R Hinton; Alice Valentin-Torres; Zhihong Chen; Bruce D Trapp; Cornelia C Bergmann; Stephen A Stohlman
Journal:  J Neuroinflammation       Date:  2015-04-22       Impact factor: 8.322

View more
  2 in total

1.  Lipopolysaccharide exposure induces oxidative damage in Caenorhabditis elegans: protective effects of carnosine.

Authors:  Jing Ma; Xiaoyuan Xu; Ranran Wang; Haijing Yan; Huijuan Yao; Hongmei Zhang; Shaowei Jiang; Ajing Xu
Journal:  BMC Pharmacol Toxicol       Date:  2020-12-03       Impact factor: 2.483

Review 2.  Carnosine, Small but Mighty-Prospect of Use as Functional Ingredient for Functional Food Formulation.

Authors:  Ivana Jukić; Nikolina Kolobarić; Ana Stupin; Anita Matić; Nataša Kozina; Zrinka Mihaljević; Martina Mihalj; Petar Šušnjara; Marko Stupin; Željka Breškić Ćurić; Kristina Selthofer-Relatić; Aleksandar Kibel; Anamarija Lukinac; Luka Kolar; Gordana Kralik; Zlata Kralik; Aleksandar Széchenyi; Marija Jozanović; Olivera Galović; Martina Medvidović-Kosanović; Ines Drenjančević
Journal:  Antioxidants (Basel)       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.